Forest Labs leads drug stocks south
Forest Laboratories lead drug stocks south early, as shares of the drug-maker lose ground on news that an FDA advisory panel has recommended the agency not approve Forest's new pulmonary drug Daxas.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here